Biogen SG&A Expense (TTM) Analysis | YCharts

Biogen, Inc. (BIIB)

220.83 -3.68 (-1.64%) USD | NASDAQ | Sep 04, 16:00

220.90 +0.06 (+0.03%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BIIB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	2.594B
March 31, 2026	2.468B
December 31, 2025	2.434B
September 30, 2025	2.431B
June 30, 2025	2.425B
March 31, 2025	2.395B
December 31, 2024	2.404B
September 30, 2024	2.332B
June 30, 2024	2.532B
March 31, 2024	2.526B
December 31, 2023	2.550B
September 30, 2023	2.574B
June 30, 2023	2.349B
March 31, 2023	2.374B
December 31, 2022	2.404B
September 30, 2022	2.559B
June 30, 2022	2.650B
March 31, 2022	2.714B
December 31, 2021	2.674B
September 30, 2021	2.693B
June 30, 2021	2.612B
March 31, 2021	2.530B
December 31, 2020	2.505B
September 30, 2020	2.363B
June 30, 2020	2.345B

Date	Value
March 31, 2020	2.377B
December 31, 2019	2.375B
September 30, 2019	2.301B
June 30, 2019	2.244B
March 31, 2019	2.173B
December 31, 2018	2.106B
September 30, 2018	2.088B
June 30, 2018	2.024B
March 31, 2018	1.938B
December 31, 2017	1.936B
September 30, 2017	1.859B
June 30, 2017	1.888B
March 31, 2017	1.950B
December 31, 2016	1.948B
September 30, 2016	1.452B
June 30, 2016	1.468B
March 31, 2016	1.467B
December 31, 2015	1.530B
September 30, 2015	2.104B
June 30, 2015	2.196B
March 31, 2015	2.281B
December 31, 2014	2.232B
September 30, 2014	2.182B
June 30, 2014	2.017B
March 31, 2014	1.871B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Ionis Pharmaceuticals, Inc.	527.56M
AbbVie, Inc.	14.67B
Regeneron Pharmaceuticals, Inc.	2.743B
Vertex Pharmaceuticals, Inc.	2.008B
Amgen, Inc.	7.019B